Psychodermatology: Exploring the intersection of the mind and skin

Dermatology Dialogues: PAs Making a Difference

Dermatology PAs not only expand access to dermatologic care but also contribute to innovations and professional development. Join us as Michael Overcash, JAAPA Dermatology Department Editor, Sarah Vicari, President of the Society of Dermatology PAs, and Cynthia Griffith, Editor-In-Chief of the Journal of Dermatology PAs (JDPA) show how Dermatology PAs empower each of us to broaden our understanding of how to manage dermatologic conditions and contribute to professional advocacy efforts.

Psychodermatology: Exploring the intersection of the mind and skin

Psychiatric skin disorders are common but access to dermatology providers is limited. Learn more about these skin disorders in this episode as Alicyn Trask, DMSc, PA-C describes the bidirectional connections between skin and mental health. And, explore how PAs can contribute to integrative care delivery for patients with primary or secondary psychiatric skin disorders.

MASLD Screening and Management

Metabolic dysfunction-associated liver disease (MASLD) is an increasingly prevalent condition that is associated with multiple comorbidities and has been identified as a significant public health risk. We, as PAs, play an important role in early detection and management. Join us as we discuss screening and management of MASLD with PA Anne Geary.

MASLD Screening and Management

Metabolic dysfunction-associated liver disease (MASLD) is an increasingly prevalent condition that is associated with multiple comorbidities and has been identified as a significant public health risk. We, as PAs, play an important role in early detection and management. Join us as we discuss screening and management of MASLD with PA Anne Geary.

World Obesity Day Special - How PAs can shape the Future of Obesity Care: Science, Access, and Comprehensive Treatment

In recognition of World Obesity Day, this JAAPA Podcast episode brings together three Physician Associates who specialize in obesity medicine to discuss the current state of obesity care. The conversation examines comprehensive treatment in the era of direct-to-consumer GLP1 prescribing, the role of multidisciplinary care, and the growing policy discussions around Medicare and Medicaid coverage for anti-obesity medications. The panel also addresses how media portrayals and weight stigma influence patient experiences, how internalized bias affects engagement in care, and the persistent disparities in screening and access to treatment. This episode highlights the critical role PAs play in advancing evidence-based obesity care and advocating for equitable, patient centered treatment.